M.Needham,F.L.Mastaglia/NeuromuscularDisorders24(2014)4–155
theresultsoflargeobservationalcommunity-basedstudieshasbeenthelackofstrictde nitionsofstatinmyopathy,andthefactthatmanystudieshavereliedonpatientself-reportingofmuscleside-e ectswithoutobjectiveassessmentbyexperiencedneuromuscularspecialists.
Theriskfactorsfordevelopingstatinmyopathyaremultipleandincludeage,exogenousin uences,nutritionalstatus,co-morbiditiesandotherconcomitantmedications,(Table1)[15,20–22]).Increasingly,geneticvariationsarebeingrecognizedtoplayaroleindeterminingbothanindividual’stherapeuticresponseandpropensityfortoxicitytostatins,andthisisthebasisforthepresentreviewRecentprogressinthis eldhasbeenprecededbytechnologicaladvancesallowingrapidgenesequencingandthedevelopmentofsinglenucleotidepolymorphism(SNP)andcopynumbervariation(CNV)databasestohelpinterpretthisinformation.
Theaimofthisreviewistosummarizestudiesinvestigatinggeneticfactorspredisposingtostatinmyopathyandmyalgia,asthe rststeptowardspharmacogenomicscreeningtoidentifyatriskindividuals.Inordertodoso,allstudiesinvestigatingstatinmyopathyormyalgiawerereviewed,andthesetermsarede nedasmuscleweaknessorpain,withorwithoutelevatedcreatinekinase,(CK).Asabackgroundtoconsideringpharmacogenomicstudiesofrelevancetostatinmyopathies,theunderlyingpathophysiologicale ectsofstatinsonmusclewill rstbereviewedbrie y,(Section2),followedbyareviewofthepharmacogenomicsstudiespublishedto-date,(Section3).Addressingclinicaltreatmentquestionsisbeyondthescopeofthisreview,andhasbeenextensivelyreviewedpreviously[15].
2.Pathophysiologicalmechanisms
Anumberofdi erentmechanismshavebeenproposedforthemyotoxice ectsofstatinsandthedevelopmentofmyopathy,(Fig.1),andthereisstilluncertaintyastotheirrelativeimportance,(reviewedin[15]).Itislikelythatcertainmechanismsaremoreimportantinsomeindividualsthanothers,andthesedi erencesmayre ectunderlyinggeneticvariationsandsusceptibilitieswhichwarrantinvestigation.
Oneofthemostimportantproposedmechanismsisreducedsynthesisoftheisoprenoidsfarnesylpyrophosphateandgeranylgeranylpyrophosphate,resultinginreducedprenylationofsmallGTPaseproteinsinvolvedincellgrowthandmaintenance[23–27].ItisknownthatGTP-bindingproteinsignalingpathwaysareactivatedbyexercise,particularlythemitogen-activatedprotein(MAP)kinases,whichareimportantinmaintainingskeletalmusclehomeostasisduringexercise-inducedstress[28,29].InhibitionofthispathwaycouldalsohelpexplaintheincreasedCKlevelsinstatin-treatedathletes[8,30,31].Anotherconsequenceofreducedfarnesyl-pyrophosphatesynthesisisimpairedproductionofubiquinone(CoenzymeQ10)[32–35],whichmayleadtomitochondrialdysfunctionandreducedenergyproduction[36].Biopsiesfromstatin-treatedpatientscanhaveincreasednumbersofCOX-negativeandragged-red bres[37–39].Howeverthesechangesaremainlyseeninolderadults(>60years),suggestingthattheremaybeanaddede ectofaging.Inaddition,CoenzymeQ10supplementationmayamelioratestatin-inducedmyopathyalthoughthishasnotbeencon rmedinallstudies[40–42].ItispossiblethatindividualswithmtDNA
Table1
Riskfactorsfordevelopingstatin-inducedmyopathyormyalgias.Advancedage,frailtyPatientfactorsFemalegenderCo-morbidities
(Especially>80years)[21]
[94]
Untreatedhypothyroidism[13,135,136]LowVitaminDlevels[137]
Chronicrenalinsu ciencyespeciallywhenassociatedwithdiabetes[21][8,31,108]
TheAmericanHeartAssociationrecommendstemporarycessationofstatinspriortomajorsurgery[21]Personalorfamilyhistoryofstatinmyopathy[13]
PhysicalexerciseSurgery
HistoryofstatinmyopathyDrugfactors
HigherstatindoseTypeofstatinInteractingdrugs
[7,138]
Higherriskwithlovastatin,simvastatinandatorvastatin,lowerwithpravastatinand uvastatin[13,16]CYP2C9enzymeinhibitorssuchaswarfarinmaya ect uvastatinandrosuvastatinlevels
CYP3A4enzymeinhibitorssuchasdiltiazem,erythromycin, uconazole,andproteaseinhibitors[139–141]aswellasgrapefruitjuice(>200mlsdaily),increaselevelsofsimvastatin,atorvastatinandlovastatinincreasingtheriskofmuscletoxicity
Gem brozil,increasesplasmaconcentrationsofsimvastatin,pravastatin,lovastatinandrosuvastatin.[142–145]Amiodaroneincreasesriskofsimvastatintoxicity(relativeriskofnearly10)[97,146]Alcoholabuse
热门文档